These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1070292)

  • 21. Pelvic exenteration and its modifications.
    Rodriguwz-Bigas MA; Petrelli NJ
    Am J Surg; 1996 Feb; 171(2):293-8. PubMed ID: 8619471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic exenteration--Medical College of Georgia experience.
    Talledo OE
    Gynecol Oncol; 1985 Oct; 22(2):181-8. PubMed ID: 4054717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
    Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
    World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of pelvic exenteration for treatment of pelvic malignancy--a nine-year experience.
    Wydra D; Emerich J; Ciach K; Sawicki S; Marciniak A
    Eur J Gynaecol Oncol; 2005; 26(4):418-22. PubMed ID: 16122192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic exenteration.
    Di Saia PJ; Morrow CP
    Calif Med; 1973 Feb; 118(2):13-7. PubMed ID: 4701706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
    Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
    Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palliative exenteration--what, when, and why?
    Stanhope CR; Symmonds RE
    Am J Obstet Gynecol; 1985 May; 152(1):12-6. PubMed ID: 2581447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic exenteration for advanced pelvic malignancies.
    Pawlik TM; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2006 May; 13(5):612-23. PubMed ID: 16538402
    [No Abstract]   [Full Text] [Related]  

  • 32. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and follow-up of total pelvic exenteration].
    Aleksic M; Hennes N; Schmitz-Dräger BJ; Ulrich B
    Chirurg; 1998 Apr; 69(4):450-4. PubMed ID: 9612632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases.
    Rodriguez Cuevas H; Torres A; de la Garza M; Hernandez D; Herrera L
    J Surg Oncol; 1988 Jun; 38(2):121-5. PubMed ID: 3288809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Operative mortality and morbidity in pelvic exenteration. Technical aspects].
    De Ranieri J; Crouet H; André M; Souloy J; Desdoits JM; Bouvet A
    J Chir (Paris); 1986 Apr; 123(4):246-50. PubMed ID: 3745309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total pelvic exenteration with simultaneous bowel and urinary reconstruction.
    Skinner DG; Sherrod A
    J Urol; 1990 Dec; 144(6):1433-8; discussion 1438-9. PubMed ID: 2231937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASO Author Reflections: Pelvic Exenteration for Patients with Primary and Recurrent Pelvic Cancer.
    Kulu Y
    Ann Surg Oncol; 2019 May; 26(5):1350. PubMed ID: 30843159
    [No Abstract]   [Full Text] [Related]  

  • 39. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
    Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
    Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
    Kraybill WG; Lopez MJ; Bricker EM
    Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.